Detalles de la búsqueda
1.
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Blood
; 143(17): 1738-1751, 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38215390
2.
FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.
Cytometry A
; 105(1): 24-35, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776305
3.
Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia.
Haematologica
; 109(3): 740-750, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345487
4.
Automated Flow Cytometric MRD Assessment in Childhood Acute B- Lymphoblastic Leukemia Using Supervised Machine Learning.
Cytometry A
; 95(9): 966-975, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31282025
5.
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
Pediatr Blood Cancer
; 66(5): e27590, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30561169
6.
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study.
Haematologica
; 103(9): 1484-1492, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29773602
7.
Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups.
Pediatr Blood Cancer
; 64(12)2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28598536
8.
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid.
Pediatr Blood Cancer
; 64(8)2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28111878
9.
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.
Blood
; 122(1): 37-43, 2013 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23704089
10.
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.
Blood
; 120(16): 3187-205, 2012 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-22879540
11.
The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01.
Haematologica
; 99(9): 1472-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24763401
12.
CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia.
Haematologica
; 104(8): e352-e355, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30705095
13.
Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.
Blood Adv
; 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621200
14.
The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
Br J Haematol
; 161(4): 556-65, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23480776
15.
Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16).
Blood
; 118(20): 5409-15, 2011 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21948298
16.
Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study.
Blood
; 117(26): 7102-11, 2011 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21551233
17.
Outcome of children and adolescents with a second or third relapse of acute lymphoblastic leukemia (ALL): a population-based analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) study group.
J Pediatr Hematol Oncol
; 35(5): e200-4, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23652878
18.
Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).
Paediatr Drugs
; 25(6): 719-728, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37695474
19.
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.
J Clin Oncol
; 41(16): 2963-2974, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996387
20.
Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data.
Cytometry A
; 81(1): 25-34, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21990127